Connacht Asset Management’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-60
Closed -$194K 173
2022
Q1
$194K Sell
60
-70
-54% -$226K 0.1% 82
2021
Q4
$813K Sell
130
-11
-8% -$68.8K 0.79% 37
2021
Q3
$1.3M Buy
141
+33
+31% +$304K 0.84% 28
2021
Q2
$1.09M Buy
+108
New +$1.09M 0.47% 44